Our work revealed the role of BAIAP2L2 in the progression of HCC, especially in the immune response, tumor microenvironment, and drug resistance, indicating that it could be crucial for developing tailored cancer therapies. The gene discussed is BAIAP2L2; the disease is neoplasm.